๎
๎ผ
๎
Apogee Therapeutics Inc
APGE70.390USD
-0.530-0.75%
์ข
๊ฐย 11/26, 16:00๏ผET๏ผ์์ธ๋ 15๋ถ ์ง์ฐ๋ฉ๋๋ค
4.18B์๊ฐ์ด์ก
์์คP/E TTM
๎
์์ธํ ๋ด์ฉ์ Apogee Therapeutics Inc ํ์ฌ
Apogee Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), asthma and other inflammatory and immunology (I&I) indications with high unmet need. Its advanced programs are APG777 and APG808, which are developed for the treatment of AD and COPD, respectively. APG777 is a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) targeting IL-13. APG808 is an SQ extended half-life mAb targeting IL-4Rฮฑ. Its earlier-stage programs, APG990 and APG222, utilize advanced antibody engineering to target OX40L and both IL-13 and OX40L, which are developed for the treatment of AD. APG990 is an SQ extended half-life mAb targeting OX40L for the treatment of AD. APG222 is one or more extended half-life SQ antibodies targeting both IL-13 and OX40L, which has the potential to improve outcomes in AD.
Apogee Therapeutics Inc ์ ๋ณด
๎์ข
๋ชฉ ์ฝ๋ APGE
ํ์ฌ ์ด๋ฆApogee Therapeutics Inc
์์ฅ์ผJul 14, 2023
CEODr. Michael Henderson, M.D.
์ง์ ์196
์ ํOrdinary Share
ํ๊ณ ์ฐ๋ ์ข
๋ฃJul 14
์ฃผ์221 Crescent St.
๋์WALTHAM
์ฆ๊ถ ๊ฑฐ๋์NASDAQ Global Market Consolidated
๊ตญ๊ฐUnited States of America
์ฐํธ ๋ฒํธ02453
์ ํ16503945230
์น์ฌ์ดํธhttps://apogeetherapeutics.com/
์ข
๋ชฉ ์ฝ๋ APGE
์์ฅ์ผJul 14, 2023
CEODr. Michael Henderson, M.D.
Apogee Therapeutics Inc์ ํ์ฌ ์์์ง
๎์ด๋ฆ
์ด๋ฆ/์ง์
์ง์
์ฃผ์ ๋ณด์
๋ณ๋
Mr. Carl Dambkowski, M.D.
Mr. Carl Dambkowski, M.D.
Chief Medical Officer
Chief Medical Officer
123.55K
-2.16%
Mr. Tomas Kiselak
Mr. Tomas Kiselak
Independent Director
Independent Director
51.17K
--
Mr. Mark C. Mckenna
Mr. Mark C. Mckenna
Independent Chairman of the Board
Independent Chairman of the Board
20.00K
--
Mr. Nimish Shah
Mr. Nimish Shah
Independent Director
Independent Director
--
--
Mr. Peter Harwin
Mr. Peter Harwin
Independent Director
Independent Director
--
--
Mr. William (Bj) Jones, Jr.
Mr. William (Bj) Jones, Jr.
Independent Director
Independent Director
--
--
Ms. Jennifer Fox
Ms. Jennifer Fox
Independent Director
Independent Director
--
--
Dr. Michael Henderson, M.D.
Dr. Michael Henderson, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Andrew Gottesdiener, M.D.
Dr. Andrew Gottesdiener, M.D.
Independent Director
Independent Director
--
--
Ms. Jane Pritchett Henderson
Ms. Jane Pritchett Henderson
Chief Financial Officer
Chief Financial Officer
--
--
๋ ๋ณด๊ธฐ
์ด๋ฆ
์ด๋ฆ/์ง์
์ง์
์ฃผ์ ๋ณด์
๋ณ๋
Mr. Carl Dambkowski, M.D.
Mr. Carl Dambkowski, M.D.
Chief Medical Officer
Chief Medical Officer
123.55K
-2.16%
Mr. Tomas Kiselak
Mr. Tomas Kiselak
Independent Director
Independent Director
51.17K
--
Mr. Mark C. Mckenna
Mr. Mark C. Mckenna
Independent Chairman of the Board
Independent Chairman of the Board
20.00K
--
Mr. Nimish Shah
Mr. Nimish Shah
Independent Director
Independent Director
--
--
Mr. Peter Harwin
Mr. Peter Harwin
Independent Director
Independent Director
--
--
Mr. William (Bj) Jones, Jr.
Mr. William (Bj) Jones, Jr.
Independent Director
Independent Director
--
--
์์ต ๋ถ์
๊ธฐ์
์ด ์์ง ๊ด๋ จ ๋ฐ์ดํฐ๋ฅผ ๊ณต๊ฐํ์ง ์์์ต๋๋ค.
๊ธฐ์
์ด ์์ง ๊ด๋ จ ๋ฐ์ดํฐ๋ฅผ ๊ณต๊ฐํ์ง ์์์ต๋๋ค.
์ฌ์
๋ณ
์ง์ญ๋ณ
๊ธฐ์
์ด ์์ง ๊ด๋ จ ๋ฐ์ดํฐ๋ฅผ ๊ณต๊ฐํ์ง ์์์ต๋๋ค.
์ฃผ์ ๋ณด์ ํต๊ณ
๋ง์ง๋ง ์
๋ฐ์ดํธ: Sun, Nov 16
๋ง์ง๋ง ์
๋ฐ์ดํธ: Sun, Nov 16
์ฃผ์ฃผ
์ฃผ์ฃผ ์ ํ
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น์จ
VR Adviser, LLC
15.49%
Fidelity Management & Research Company LLC
12.55%
Wellington Management Company, LLP
8.61%
RTW Investments L.P.
4.95%
BlackRock Institutional Trust Company, N.A.
4.45%
๊ธฐํ
53.96%
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น์จ
VR Adviser, LLC
15.49%
Fidelity Management & Research Company LLC
12.55%
Wellington Management Company, LLP
8.61%
RTW Investments L.P.
4.95%
BlackRock Institutional Trust Company, N.A.
4.45%
๊ธฐํ
53.96%
์ฃผ์ฃผ ์ ํ
์ฃผ์ฃผ
๋น์จ
Investment Advisor
34.10%
Investment Advisor/Hedge Fund
33.20%
Hedge Fund
20.35%
Venture Capital
17.44%
Corporation
3.99%
Research Firm
3.93%
Private Equity
2.47%
Individual Investor
2.34%
Bank and Trust
0.27%
๊ธฐ๊ด ์ฃผ์ ๋ณด์
๎๋ง์ง๋ง ์
๋ฐ์ดํธ: Wed, Oct 1
๋ง์ง๋ง ์
๋ฐ์ดํธ: Wed, Oct 1
๋ณด๊ณ ๊ธฐ๊ฐ
๊ธฐ๊ด ์
๋ณด์ ์ฃผ์
๋น์จ
๋ณ๋
2025Q3
384
60.96M
115.64%
-6.54M
2025Q2
361
64.81M
140.75%
-3.82M
2025Q1
358
68.35M
148.52%
-1.29M
2024Q4
327
64.90M
141.09%
-712.20K
2024Q3
294
62.28M
112.13%
-1.08M
2024Q2
266
60.08M
139.61%
+8.71M
2024Q1
229
52.05M
122.88%
+15.40M
2023Q4
155
40.73M
116.78%
+8.63M
2023Q3
114
37.13M
101.02%
+18.30M
์ฃผ์ฃผ ํ๋
๎์ด๋ฆ
๋ณด์ ์ฃผ์
๋น์จ
๋ณ๋
Chg %
๋ ์ง
VR Adviser, LLC
8.49M
18.42%
--
--
Jun 30, 2025
Fidelity Management & Research Company LLC
6.64M
14.39%
-379.63K
-5.41%
Jun 30, 2025
Wellington Management Company, LLP
4.89M
10.59%
+1.08M
+28.36%
Jul 31, 2025
RTW Investments L.P.
2.71M
5.88%
--
--
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
2.30M
5%
-335.94K
-12.73%
Jun 30, 2025
The Vanguard Group, Inc.
2.10M
4.56%
+25.18K
+1.21%
Jun 30, 2025
Access Industries, Inc.
2.19M
4.75%
+250.00K
+12.88%
Sep 30, 2024
Driehaus Capital Management, LLC
2.31M
5.01%
-28.81K
-1.23%
Jun 30, 2025
Fairmount Funds Management LLC
2.05M
4.44%
--
--
Jun 30, 2025
State Street Investment Management (US)
1.26M
2.73%
-54.49K
-4.15%
Jun 30, 2025
๋ ๋ณด๊ธฐ
๊ด๋ จ ETF
๎๋ง์ง๋ง ์
๋ฐ์ดํธ: Thu, Nov 6
๋ง์ง๋ง ์
๋ฐ์ดํธ: Thu, Nov 6
์ด๋ฆ
๋น์จ
ALPS Medical Breakthroughs ETF
1.1%
Goldman Sachs Future Health Care Equity ETF
0.74%
Virtus LifeSci Biotech Clinical Trials ETF
0.68%
SPDR S&P Biotech ETF
0.67%
First Trust Multi-Manager Small Cap Opportunities ETF
0.39%
Direxion Daily S&P Biotech Bull 3X Shares
0.35%
JPMorgan Fundamental Data Science Small Core ETF
0.21%
ProShares Ultra Nasdaq Biotechnology
0.19%
Invesco Nasdaq Biotechnology ETF
0.18%
iShares Biotechnology ETF
0.14%
๋ ๋ณด๊ธฐ
ALPS Medical Breakthroughs ETF
๋น์จ1.1%
Goldman Sachs Future Health Care Equity ETF
๋น์จ0.74%
Virtus LifeSci Biotech Clinical Trials ETF
๋น์จ0.68%
SPDR S&P Biotech ETF
๋น์จ0.67%
First Trust Multi-Manager Small Cap Opportunities ETF
๋น์จ0.39%
Direxion Daily S&P Biotech Bull 3X Shares
๋น์จ0.35%
JPMorgan Fundamental Data Science Small Core ETF
๋น์จ0.21%
ProShares Ultra Nasdaq Biotechnology
๋น์จ0.19%
Invesco Nasdaq Biotechnology ETF
๋น์จ0.18%
iShares Biotechnology ETF
๋น์จ0.14%
์ฃผ์ ๋ฐฐ๋น๊ธ
๎์ง๋ 5๋
๋์ ์ด
0.00
USD์ ๋ฐฐ๋น๊ธ์ด ๋ถ๋ฐฐ๋์์ต๋๋ค.
๋ ์ง
๋ฐฐ๋น๊ธ
๊ธฐ์ค์ผ
์ง๊ธ์ผ
๋ฐฐ๋น๋ฝ์ผ
๋ฐ์ดํฐ ์์
์ฃผ์ ๋ถํ
๎๋ ์ง
์ ํ
๋น์จ
๋ฐ์ดํฐ ์์
๋ ์ง
์ ํ
๋น์จ
๋ฐ์ดํฐ ์์
์์ฃผ ๋ฌป๋ ์ง๋ฌธ
Apogee Therapeutics Inc์ ์์ 5๋ ์ฃผ์ฃผ๋ ๋๊ตฌ์ธ๊ฐ์?
๎Apogee Therapeutics Inc์ ์์ 5๋ ์ฃผ์ฃผ๋ ๋ค์๊ณผ ๊ฐ์ต๋๋ค:
VR Adviser, LLC๋ 8.49M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 18.42%๋ฅผ ์ฐจ์งํฉ๋๋ค.
Fidelity Management & Research Company LLC๋ 6.64M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 14.39%๋ฅผ ์ฐจ์งํฉ๋๋ค.
Wellington Management Company, LLP๋ 4.89M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 10.59%๋ฅผ ์ฐจ์งํฉ๋๋ค.
RTW Investments L.P.๋ 2.71M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 5.88%๋ฅผ ์ฐจ์งํฉ๋๋ค.
BlackRock Institutional Trust Company, N.A.๋ 2.30M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 5.00%๋ฅผ ์ฐจ์งํฉ๋๋ค.
VR Adviser, LLC๋ 8.49M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 18.42%๋ฅผ ์ฐจ์งํฉ๋๋ค.
Fidelity Management & Research Company LLC๋ 6.64M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 14.39%๋ฅผ ์ฐจ์งํฉ๋๋ค.
Wellington Management Company, LLP๋ 4.89M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 10.59%๋ฅผ ์ฐจ์งํฉ๋๋ค.
RTW Investments L.P.๋ 2.71M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 5.88%๋ฅผ ์ฐจ์งํฉ๋๋ค.
BlackRock Institutional Trust Company, N.A.๋ 2.30M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 5.00%๋ฅผ ์ฐจ์งํฉ๋๋ค.
Apogee Therapeutics Inc์ ์์ 3๋ ์ฃผ์ฃผ ์ ํ์ ๋ฌด์์ธ๊ฐ์?
๎Apogee Therapeutics Inc์ ์ฃผ์ ์ฃผ์ฃผ ์ ํ ์์ 3๊ฐ์ง๋
VR Adviser, LLC
Fidelity Management & Research Company LLC
Wellington Management Company, LLP์ ๋๋ค.
VR Adviser, LLC
Fidelity Management & Research Company LLC
Wellington Management Company, LLP์ ๋๋ค.
Apogee Therapeutics Inc(APGE)์ ์ฃผ์์ ๋ณด์ ํ ๊ธฐ๊ด์ ๋ช ๊ฐ์ ๋๊น?
๎2025Q3 ๊ธฐ์ค์ผ๋ก, Apogee Therapeutics Inc์ ์ฃผ์์ ๋ณด์ ํ ๊ธฐ๊ด์ ์ด 384๊ณณ์ด๋ฉฐ, ์ด๋ค์ด ๋ณด์ ํ ์ฃผ์์ ์ด ๊ฐ์น๋ ์ฝ 60.96M๋ก ์ ์ฒด ๋ฐํ ์ฃผ์์ 115.64%๋ฅผ ์ฐจ์งํฉ๋๋ค. ์ด๋ 2025Q2 ๋๋น -25.10% ์ฆ๊ฐํ ์์น์
๋๋ค.
Apogee Therapeutics Inc์ ์ต๋ ์์ต์์ ๋ฌด์์ธ๊ฐ์?
๎-- ๊ธฐ์ค, Apogee Therapeutics Inc์ -- ๋ถ๋ฌธ์ด ๊ฐ์ฅ ๋์ ๋งค์ถ์ ๊ธฐ๋กํ์ผ๋ฉฐ, ๊ธ์ก์ --๋ก ์ ์ฒด ๋งค์ถ์ --%๋ฅผ ์ฐจ์งํ์ต๋๋ค.
